investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Modeling and Targeting Adaptive Signaling Responses in Single NRAS Mutant Melanoma Cells
Keiran Smalley
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
No posts
Related projects
Dean W Felsher
Modeling and Predicting Therapeutic Resistance of Cancer
Melanoma of skin
Bruce Furie
Protein disulfide isomerases: A new class of antithrombotic targets
Melanoma of skin
Peter S. Choi
Defining the role of RBM10 in RNA processing and tumor suppression
Melanoma of skin
Gajanana Datta
Improved metabolic imaging using hyperpolarized 13C MR substrates
Melanoma of skin
Jiangbin Ye
Hypoxia induces SHMT2 to regulate cellular redox and epigenetics
Melanoma of skin
Richard I. Gregory
Screening for drugs that restore let-7 microRNA expression in cancer
Melanoma of skin
Bing Xu
Enzyme-instructed self-assembly for molecular anticancer nanomedicines
Melanoma of skin
Deborah Morrison
Regulation of Ras-Dependent Signal Transduction Pathways
Melanoma of skin
Peter S. Nelson
Resistance to Cancer Therapeutics Through Microenvironment Damage Responses
Melanoma of skin
